|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
A crowd of executives went to Capitol Hill Thursday to convince lawmakers that the U.S. tax code gives unfair advantages to their foreign competitors. Is that true, or are companies simply looking for a tax break?
Zimmer Holdings Incorporated (NYSE:ZMH) hit a new 52-week high Thursday as it is currently trading at $66.80, above its previous 52-week high of $66.75 with 663,630 shares traded as of 11:43 a.m. ET. Average volume has been 1.6 million shares over the past 30 days.
The numbers will be released in Thursday's premarket and could show a resilient consumer ready to spend even more this summer.
Zimmer Holdings Incorporated (NYSE:ZMH) has been upgraded by TheStreet Ratings from a hold to buy.
Zimmer Holdings' CEO Discusses Q1 2011 Results - Earnings Call Transcript
After a dreadful 2010, health-care stocks like Pfizer, Medtronics and Johnson & Johnson could make a full recovery this year.
Pfizer, UnitedHealth and Johnson & Johnson may rebound this year, American Century's Michael Liss says.
Gregg Greenberg breaks down today's market action. Guests include Michael Liss, portfolio manager for the American Century Value Fund, David Green, portfolio manager for the Hotchkis and Wiley Value Opportunities Fund and Kathleen Gaffney, portfolio manager for the Loomis Sayles Bond Fund
Next week's trading focus will be on companies reporting earnings, as they will provide the best read on what the U.S. and global economies look like with $100-a-barrel oil.
Zimmer Holdings Incorporated (NYSE:ZMH) hit a new 52-week high Friday as it changed hands at $63.23 compared with its previous 52-week high of $62.50. Zimmer is currently trading at $62.66 with 197,258 shares changing hands as of 9:32 a.m..
Zimmer Holdings CEO Discusses Q4 2010 Earnings Call Transcript
Zimmer Holdings receives a five-star rating from Morningstar and greater support from institutions.
The medical devices and technology sectors could be a source of stable low-risk growth in the future as more money is focused on health care and baby boomers enter their golden years.
Full speed ahead or stay on sidelines? 5 tips on how investors should proceed in this market
Zimmer Holdings, Inc. Q1 2010 Earnings Call Transcript
Cramer discusses the miscalculations he made in assessing the market reaction to health care reform vote.
Cramer likes the company and thinks high-end retail is rocking.
Cramer expects Goldman Sachs and JPMorgan to be the latest stocks to bounce back after being the target of the president's wrath.
Analyst upgrades Boston Scientific and Zimmer, lifts estimates on peers citing decreased risk
FDA panel rejects Zimmer spine repair device on questions of safety and effectiveness
Health regulators probe influence of financial payments on Zimmer spinal implant study
Health bill hits insurers, drugs, medical devices as Dems search for votes, money to pass plan
Zimmer Holdings profit falls 30 percent amid 1-time costs, loss on interest
Enbridge, Ingersoll-Rand, Valassis, Exide Technologies and Zimmer Holdings had their ratings changed by TheStreet.com.
Movers roundup: Robbins & Myers shares fall on weak outlook, Semitool climbs on 4Q guidance
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.